{"id":263,"date":"2024-06-10T16:31:06","date_gmt":"2024-06-10T07:31:06","guid":{"rendered":"https:\/\/www.den.hokudai.ac.jp\/microbiology\/?page_id=263"},"modified":"2024-06-10T19:16:58","modified_gmt":"2024-06-10T10:16:58","slug":"achievements-2006","status":"publish","type":"page","link":"https:\/\/www.den.hokudai.ac.jp\/microbiology\/achievements-2006\/","title":{"rendered":"2006"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">\u539f\u8457\u8ad6\u6587<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16951535?dopt=AbstractPlus\">Tsutsumi K, Yasuda M, Nishioka T. X-ray irradiation altered chemosensitivity of a p53-null non-small cell lung cancer cell line.&nbsp;<em>Cell Struct Funct.<\/em>&nbsp;2006; 31:47-52.<\/a>&nbsp;<\/li>\n\n\n\n<li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16982924?dopt=AbstractPlus\">Hasebe A, Pennock ND, Mu HH, Chan FV, Cole BC. A microbial TLR2-agonist imparts macrophage-activating ability to apolipoprotein A-1.&nbsp;<em>J. Immunol.<\/em>&nbsp;2006. 177: 4826-4832.<\/a>&nbsp;<\/li>\n\n\n\n<li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16723649?dopt=AbstractPlus\">Sugawara Y, Uehara A, Fujimoto Y, Kusumoto S, Fukase K, Shibata K, Sugawara S, Sasano T, Takada H. Toll-like receptors, NOD1, and NOD2 in oral epithelial cells.&nbsp;<em>J. Dent. Res.<\/em>&nbsp;2006. 85: 524-529.&nbsp;<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16302262?dopt=AbstractPlus\">Takeyama K, Mitsuzawa H, Shimizu T, Konishi M, Nishitani C, Sano H, Kunishima Y, Matsukawa M, Takahashi S, Shibata K, Tsukamoto T, Kuroki Y. The prostate cell lines secrete IL-8 in response to&nbsp;<em>Mycoplasma hominis<\/em>&nbsp;through Toll-like receptor 2-mediated mechanism (PROS-05-259). <em>The Prostate<\/em>&nbsp;66: 386-391. 2006.&nbsp;<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16420600?dopt=AbstractPlus\">Kiura K, Kataoka H, Nakata T, Into T, Yasuda M, Akira S, Inoue N, Shibata K. The synthetic analogue of mycoplasmal lipoprotein FSL-1 induces dendritic cell maturation through TLR2.&nbsp;<em>FEMS Immunol. Med. Microbiol.<\/em>&nbsp;;46: 78-84.2006.<\/a>&nbsp;<\/li>\n\n\n\n<li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16819971?dopt=AbstractPlus\">Kataoka H, Yasuda M, Iyori M, Kiura K, Narita M, Nakata T, Shibata K. Roles of N-linked glycans in the recognition of microbial lipopeptides and lipoproteins by TLR2. <em>Cell. Microbiol.<\/em>\u00a08: 1199-1207. 2006.\u00a0<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16965351?dopt=AbstractPlus\">Kiura K, Kataoka H, Yasuda M, Inoue N, Shibata K. The diacylated lipopeptide FSL-1 induces TLR2-mediated Th2 responses.&nbsp;<em>FEMS Immunol. Med. Microbiol.<\/em>&nbsp;2006. 48: 44-55.&nbsp;<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16848791?dopt=AbstractPlus\">Nakata T, Yasuda M, Fujita M, Kataoka H, Kiura K, Sano H, Shibata K. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex.&nbsp;<em>Cell. Microbiol<\/em>. 11, 2006.<\/a>&nbsp;<\/li>\n\n\n\n<li>\u4f50\u85e4\u3000\u7fa9\u502b\u3001\u5b87\u5c3e\u3000\u57fa\u5f18\u3001\u6a2a\u5c71\u3000\u6566\u90ce\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce\u3001\u4e98\u7406\u3000\u6587\u592b\u3001\u7530\u8def\u3000\u548c\u5e78. \u30ab\u30fc\u30dc\u30f3\u30ca\u30ce\u30c1\u30e5\u30fc\u30d6\u3068\u91d1\u5c5e\u5185\u5305\u30ab\u30fc\u30dc\u30f3\u30ca\u30ce\u30ab\u30d7\u30bb\u30eb\u306e\u6bd2\u6027\u8a55\u4fa1. \u8868\u9762. 44(3): 1(87)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">\u7dcf\u8aac\u30fb\u89e3\u8aac\u30fb\u8a55\u8ad6<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u7247\u5ca1\u3000\u55e3\u96c4\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce\uff0eToll-like receptor 2 \u306b\u3088\u308b\u5fae\u751f\u7269\u7531\u6765\u30ea\u30dd\u30da\u30d7\u30c1\u30c9\u30fb\u30ea\u30dd\u30bf\u30f3\u30d1\u30af\u8a8d\u8b58\u304a\u3051\u308b\u30a2\u30b9\u30d1\u30e9\u30ae\u30f3\u7d50\u5408\u578b\u7cd6\u9396\u306e\u5f79\u5272.&nbsp;<em>\u65e5\u672c\u30a8\u30f3\u30c9\u30c8\u30ad\u30b7\u30f3\u7814\u7a76<\/em>\u30009\uff1a142-151\uff0e<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">\u56fd\u969b\u5b66\u4f1a\u767a\u8868<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Hasebe A, Pennock ND, Mu HH, Chan FV, Cole BC.&nbsp;<em>Mycoplasma arthritidis<\/em>&nbsp;Transfers TLR2-dependent Bioactivity To Apolipoprotein A-1: Possible Implications For Athersclerosis. The International Organization for Mycoplasmology 16th International Congress. IOM abstract # 20, page, 30 July 9. 2006 St John&#8217;s College, Cambridge, UK<\/li>\n\n\n\n<li>Kiura K, Kataoka H, Yasuda M, Inoue N, Shibata K. The diacylated lipopeptide FSL-1 induces Th-2 mediated adjuvant activity. Innate Immunity in Cancer and Infectious Diseases (The 26th International Symposium of the Sapporo Cancer Seminar Foundation). P-1. July 21-23. 2006 Sapporo.<\/li>\n\n\n\n<li>Yasuda M, Nakata T, Iyori M, Shibata K. Gene expressions from human adenovirus E1 region modify the host innate immune responses via TLR2\/4pathways. Innate Immunity in Cancer and Infectious Diseases (The 26th International Symposium of the Sapporo Cancer Seminar Foundation). P-2. July 21-23. 2006 Sapporo.<\/li>\n\n\n\n<li>Nakata T, Yasuda M, Fujita M, Kataoka H, Kiura K, Sano H, Shibata K. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Innate Immunity in Cancer and Infectious Diseases (The 26th International Symposium of the Sapporo Cancer Seminar Foundation). P\/O-3. July 21-23. 2006 Sapporo.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">\u56fd\u5916\u5b66\u4f1a\u767a\u8868<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Mu HH, Chan FV, Hasebe A, Pennock ND, Cole BC. MHC class II molecule is permissive in TLR-mediated DC maturation and cytokine production to the mycoplasmal superantigen MAM. The 2006 KEYSTONE SYMPOSIA conference on Innate Immunity (B6), Feb. 10 &#8211; 15, 2006. Banff, Alberta, Canada (#259).<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">\u5b66\u4f1a\u767a\u8868<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u4f0a\u5f93\u3000\u5149\u6d0b\u3001\u7247\u5ca1\u3000\u55e3\u96c4\u3001\u9577\u8c37\u90e8\u3000\u6643\u3001\u5b89\u7530\u3000\u5143\u662d\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce. Resveratrol\u306b\u3088\u308b\u8caa\u98df\u907a\u4f1d\u5b50\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u5236\u5fa1. \u7b2c36\u56de\u65e5\u672c\u514d\u75ab\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. 2006\u5e7412\u670811\uff5e13\u65e5. \u5927\u962a. \u65e5\u672c\u514d\u75ab\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\u8a18\u9332. 36:132. 2006.<\/li>\n\n\n\n<li>\u7247\u5ca1\u3000\u55e3\u96c4\u3001\u4f0a\u5f93\u3000\u5149\u6d0b\u3001\u6728\u6d66\u3000\u548c\u4eba\u3001\u4e2d\u7530\u3000\u8cb4\u3001\u9577\u8c37\u90e8\u3000\u6643\u3001\u5b89\u7530\u3000\u5143\u662d\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce. DC-SIGN\u306fTLR2\u306b\u3088\u308b\u30ea\u30dd\u30da\u30d7\u30c1\u30c9\u8a8d\u8b58\u3092\u5897\u5f37\u3059\u308b. \u7b2c36\u56de\u65e5\u672c\u514d\u75ab\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. 2006\u5e7412\u670811\uff5e13\u65e5. \u5927\u962a. \u65e5\u672c\u514d\u75ab\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\u8a18\u9332. 36:40. 2006.<\/li>\n\n\n\n<li>\u9577\u8c37\u90e8\u3000\u6643\u3001Pennock ND, MU HH, Chan FV, Cole BC.&nbsp;<em>Mycoplasma arthritidis<\/em>\u306e\u57f9\u990a\u306b\u3088\u308b\u8840\u6e05\u30a2\u30dd\u30ea\u30dd\u30bf\u30f3\u30d1\u30af\u8ceaA-1\u306f\u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u6d3b\u6027\u5316\u80fd\u3092\u7372\u5f97\u3059\u308b. \u7b2c36\u56de\u65e5\u672c\u514d\u75ab\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. 2006\u5e7412\u670811\uff5e13\u65e5. \u5927\u962a. \u65e5\u672c\u514d\u75ab\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\u8a18\u9332. 36:40. 2006.<\/li>\n\n\n\n<li>Yasuda M, Nakata T, Iyori M, Kiura K, Kataoka H, Shibata K. Human adenoviral proteins modify the host innate immune responses via E2F pathways. \u7b2c36\u56de\u65e5\u672c\u514d\u75ab\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. 2006\u5e7412\u670811\uff5e13\u65e5. \u5927\u962a. \u65e5\u672c\u514d\u75ab\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\u8a18\u9332. 36:201. 2006.<\/li>\n\n\n\n<li>\u9577\u8c37\u90e8\u3000\u6643. \u30a2\u30dd\u30ea\u30dd\u30bf\u30f3\u30d1\u30af\u8ceaA-1\u306f<em>Mycoplasma arthritidis<\/em>\u57f9\u990a\u306b\u3088\u308a\u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u6d3b\u6027\u80fd\u3092\u7372\u5f97\u3059\u308b. \u5317\u6d77\u9053\u6b6f\u5b66\u4f1a\u79cb\u5b63\u5b66\u8853\u5927\u4f1a\u30002006\u5e7411\u670817\uff5e18\u65e5. \u5317\u6d77\u9053\u6b6f\u5b66\u4f1a \u79cb\u5b63\u5b66\u8853\u5927\u4f1a\u30d7\u30ed\u30b0\u30e9\u30e0\u8b1b\u6f14\u5185\u5bb9\u6284\u9332. 2006.<\/li>\n\n\n\n<li>\u4e2d\u7530\u3000\u8cb4. CD14\u306fTLR2\/1\u8907\u5408\u4f53\u306b\u7d50\u5408\u3059\u308b\u3053\u3068\u306a\u304fTLR2\/TLR1\u8907\u5408\u4f53\u306b\u3088\u308b\u30ea\u30dd\u30da\u30d7\u30c1\u30c9\u8a8d\u8b58\u3092\u5897\u5f37\u3055\u305b\u308b. \u5317\u6d77\u9053\u6b6f\u5b66\u4f1a\u79cb\u5b63\u5b66\u8853\u5927\u4f1a\u30002006\u5e7411\u670817\uff5e18\u65e5. \u5317\u6d77\u9053\u6b6f\u5b66\u4f1a \u79cb\u5b63\u5b66\u8853\u5927\u4f1a\u30d7\u30ed\u30b0\u30e9\u30e0\u8b1b\u6f14\u5185\u5bb9\u6284\u9332. 2006.<\/li>\n\n\n\n<li>\u524d\u3000\u591a\u539a. \u30b8\u30a2\u30b7\u30eb\u30ea\u30dd\u30da\u30d7\u30c1\u30c9FSL-1\u306f\u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u306b\u3088\u308b\u7d30\u83cc\u306e\u8caa\u98df\u3092TLR2\u4f9d\u5b58\u7684\u306b\u5897\u52a0\u3055\u305b\u308b. \u5317\u6d77\u9053\u6b6f\u5b66\u4f1a\u79cb\u5b63\u5b66\u8853\u5927\u4f1a\u30002006\u5e7411\u670817\uff5e18\u65e5. \u5317\u6d77\u9053\u6b6f\u5b66\u4f1a \u79cb\u5b63\u5b66\u8853\u5927\u4f1a\u30d7\u30ed\u30b0\u30e9\u30e0\u8b1b\u6f14\u5185\u5bb9\u6284\u9332. 2006.<\/li>\n\n\n\n<li>\u7247\u5ca1\u3000\u55e3\u96c4, TLR2\u306b\u3088\u308b\u7d30\u83cc\u7531\u6765\u30ea\u30dd\u30bf\u30f3\u30d1\u30af\u8cea\u30fb\u30ea\u30dd\u30da\u30d7\u30c1\u30c9\u306e\u8a8d\u8b58\u306b\u304a\u3051\u308bN\u7d50\u5408\u578b\u7cd6\u9396\u306e\u5f79\u5272. \u5317\u6d77\u9053\u6b6f\u5b66\u4f1a\u79cb\u5b63\u5b66\u8853\u5927\u4f1a\u30002006\u5e7411\u670817\uff5e18\u65e5. \u5317\u6d77\u9053\u6b6f\u5b66\u4f1a \u79cb\u5b63\u5b66\u8853\u5927\u4f1a\u30d7\u30ed\u30b0\u30e9\u30e0\u8b1b\u6f14\u5185\u5bb9\u6284\u9332. 2006.<\/li>\n\n\n\n<li>\u6728\u6d66\u3000\u548c\u4eba\u3001\u5b89\u7530\u3000\u5143\u662d\u3001\u7247\u5ca1\u3000\u55e3\u96c4\u3001\u4e95\u4e0a\u3000\u8fb2\u592b\u7537\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce. \u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u7531\u6765\u306elipopeptide (FSL-1)\u306e\u30a2\u30b8\u30e5\u30d0\u30f3\u30c8\u6d3b\u6027. \u7b2c79\u56de\u65e5\u672c\u7d30\u83cc\u5b66\u4f1a\u7dcf\u4f1a. III-G-2. 2006\u5e743\u670829\uff5e31\u65e5. \u91d1\u6ca2. \u65e5\u672c\u7d30\u83cc\u5b66\u96d1\u8a8c. 61(1): 147. 2006.<\/li>\n\n\n\n<li>\u5b89\u7530\u3000\u5143\u662d\u3001\u7247\u5ca1\u3000\u55e3\u96c4\u3001\u4f0a\u5f93\u3000\u5149\u6d0b\u3001\u6728\u6d66\u3000\u548c\u4eba\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce. \u30d2\u30c8\u30a2\u30c7\u30ce\u30a6\u30a4\u30eb\u30b9\u306f\u5bbf\u4e3b\u7d30\u80de\u306e\u7d30\u83cc\u306b\u5bfe\u3059\u308b\u81ea\u7136\u514d\u75ab\u5fdc\u7b54\u3092\u6291\u5236\u3059\u308b. \u7b2c79\u56de\u65e5\u672c\u7d30\u83cc\u5b66\u4f1a\u7dcf\u4f1a. III-G-2. 2006\u5e743\u670829\uff5e31\u65e5. \u91d1\u6ca2. \u65e5\u672c\u7d30\u83cc\u5b66\u96d1\u8a8c. 61(1): 148. 2006.<\/li>\n\n\n\n<li>\u524d\u3000\u591a\u539a\u3001\u4f0a\u5f93\u3000\u5149\u6d0b\u3001\u5b89\u7530\u3000\u5143\u662d\u3001Haque Mohhamad Shamsul\u3001\u7247\u5ca1\u3000\u55e3\u96c4\u3001\u6728\u6d66\u3000\u548c\u4eba\u3001\u6238\u585a\u3000\u9756\u5247\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce. \u30b8\u30a2\u30b7\u30eb\u30ea\u30dd\u30da\u30d7\u30c1\u30c9FSL-1\u306f\u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u306b\u3088\u308b\u7d30\u83cc\u306e\u8caa\u98df\u3092TLR2\u4f9d\u5b58\u7684\u306b\u5897\u52a0\u3055\u305b\u308b. \u65e5\u672c\u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u5b66\u4f1a\u7b2c33\u56de\u5b66\u8853\u96c6\u4f1a. 2006\u5e746\u67082\u65e5. \u6771\u4eac. \u65e5\u672c\u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u5b66\u4f1a\u7b2c33\u56de\u5b66\u8853\u96c6\u4f1a\u8b1b\u6f14\u8981\u65e8\u96c6: 32.<\/li>\n\n\n\n<li>\u6728\u6d66\u3000\u548c\u4eba\u3001\u7247\u5ca1\u3000\u55e3\u96c4\u3001\u5b89\u7530\u3000\u5143\u662d\u3001\u4e95\u4e0a\u3000\u8fb2\u592b\u7537\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce. \u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u7531\u6765\u306e\u30ea\u30dd\u30da\u30d7\u30c1\u30c9 (FSL-1)\u306b\u3088\u308bTh2\u5fdc\u7b54. \u65e5\u672c\u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u5b66\u4f1a\u7b2c33\u56de\u5b66\u8853\u96c6\u4f1a. 2006\u5e746\u67082\u65e5. \u6771\u4eac. \u65e5\u672c\u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u5b66\u4f1a\u7b2c33\u56de\u5b66\u8853\u96c6\u4f1a\u8b1b\u6f14\u8981\u65e8\u96c6: 33.<\/li>\n\n\n\n<li>\u9577\u8c37\u90e8\u3000\u6643\u3001Pennock ND, MU HH, Chan FV, Cole BC.&nbsp;<em>Mycoplasma arthritidis<\/em>\u306b\u3088\u308b\u30a2\u30dd\u30ea\u30dd\u30bf\u30f3\u30d1\u30af\u8ceaA-1\u306e\u751f\u7269\u6d3b\u6027\u306e\u7372\u5f97. \u65e5\u672c\u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u5b66\u4f1a\u7b2c33\u56de\u5b66\u8853\u96c6\u4f1a. 2006\u5e746\u67082\u65e5. \u6771\u4eac. \u65e5\u672c\u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u5b66\u4f1a\u7b2c33\u56de\u5b66\u8853\u96c6\u4f1a\u8b1b\u6f14\u8981\u65e8\u96c6: 34.<\/li>\n\n\n\n<li>\u9577\u8c37\u90e8\u3000\u6643\u3001Pennock ND, MU HH, Chan FV, Cole BC.&nbsp;<em>Mycoplasma arthritidis<\/em>\u306e\u57f9\u990a\u306b\u3088\u308b\u8840\u6e05\u30a2\u30dd\u30ea\u30dd\u30bf\u30f3\u30d1\u30af\u8ceaA-1\u306e\u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u6d3b\u6027\u5316\u80fd\u306e\u7372\u5f97. \u7b2c74\u56de \u65e5\u672c\u7d30\u83cc\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u5b66\u8853\u7dcf\u4f1a. 2006\u5e749\u67082\u65e5. \u672d\u5e4c. \u7b2c74\u56de \u65e5\u672c\u7d30\u83cc\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u5b66\u8853\u7dcf\u4f1a\u6284\u9332\u96c6: 24.<\/li>\n\n\n\n<li>\u7247\u5ca1\u3000\u55e3\u96c4\u3001\u4f0a\u5f93\u3000\u5149\u6d0b\u3001\u6728\u6d66\u3000\u548c\u4eba\u3001\u4e2d\u7530\u3000\u8cb4\u3001\u9577\u8c37\u90e8\u3000\u6643\u3001\u5b89\u7530\u3000\u5143\u662d\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce. \u30ea\u30dd\u30da\u30d7\u30c1\u30c9\u8a8d\u8b58\u306b\u304a\u3051\u308bDC-SIGN\u3068Toll-like receptor 2\u306e\u76f8\u4e57\u4f5c\u7528. \u7b2c74\u56de \u65e5\u672c\u7d30\u83cc\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u5b66\u8853\u7dcf\u4f1a. 2006\u5e749\u67082\u65e5. \u672d\u5e4c. \u7b2c74\u56de \u65e5\u672c\u7d30\u83cc\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u5b66\u8853\u7dcf\u4f1a\u6284\u9332\u96c6: 26.<\/li>\n\n\n\n<li>\u5b89\u7530\u3000\u5143\u662d\u3001\u4e2d\u7530\u3000\u8cb4\u3001\u4f0a\u5f93\u3000\u5149\u6d0b\u3001\u6728\u6d66\u3000\u548c\u4eba\u3001\u7247\u5ca1\u3000\u55e3\u96c4\u3001\u9577\u8c37\u90e8\u3000\u6643\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce. \uff24\uff2e\uff21\u304c\u3093\u30a6\u30a4\u30eb\u30b9\u306e\u521d\u671f\u907a\u4f1d\u5b50\u306f\u7d30\u83cc\u306b\u5bfe\u3059\u308b\u81ea\u7136\u514d\u75ab\u5fdc\u7b54\u3092\u6291\u5236\u3059\u308b. \u7b2c74\u56de \u65e5\u672c\u7d30\u83cc\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u5b66\u8853\u7dcf\u4f1a. 2006\u5e749\u67082\u65e5. \u672d\u5e4c. \u7b2c74\u56de \u65e5\u672c\u7d30\u83cc\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u5b66\u8853\u7dcf\u4f1a\u6284\u9332\u96c6: 30.<\/li>\n\n\n\n<li>\u4f0a\u5f93\u3000\u5149\u6d0b\u3001\u7247\u5ca1\u3000\u55e3\u96c4\u3001\u9577\u8c37\u90e8\u3000\u6643\u3001\u5b89\u7530\u3000\u5143\u662d\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce. Resveratrol\u306b\u3088\u308b\u7d30\u83cc\u8caa\u98df\u306e\u6291\u5236. \u7b2c74\u56de \u65e5\u672c\u7d30\u83cc\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u5b66\u8853\u7dcf\u4f1a. 2006\u5e749\u67082\u65e5. \u672d\u5e4c. \u7b2c74\u56de \u65e5\u672c\u7d30\u83cc\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u5b66\u8853\u7dcf\u4f1a\u6284\u9332\u96c6: 32<\/li>\n\n\n\n<li>\u5b89\u7530\u3000\u5143\u662d\u3001\u4e2d\u7530\u3000\u8cb4\u3001\u4f0a\u5f93\u3000\u5149\u6d0b\u3001\u6728\u6d66\u3000\u548c\u4eba\u3001\u7247\u5ca1\u3000\u55e3\u96c4\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce. \u30d2\u30c8\u30a2\u30c7\u30ce\u30a6\u30a4\u30eb\u30b9\u521d\u671f\u907a\u4f1d\u5b50\u7fa4\u306f\u7d30\u83cc\u306b\u5bfe\u3059\u308b\u81ea\u7136\u514d\u75ab\u5fdc\u7b54\u3092\u6291\u5236\u3059\u308b. \u7b2c48\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a. 2006\u5e749\u670821\uff5e23\u65e5. \u6a2a\u6d5c. J. Oral.Biosci. 48S: 122.<\/li>\n\n\n\n<li>\u5f15\u982d\u3000\u6bc5\u3001\u4e2d\u5cf6\u3000\u7f8e\u7802\u5b50\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce\u3001\u677e\u4e0b\u3000\u5065\u4e8c. \u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306eToll-like receptor 2\u306fMyD88\u4f9d\u5b58\u7684\u306bWeibel-Palade\u5c0f\u4f53\u30a8\u30af\u30bd\u30b5\u30a4\u30c8\u30fc\u30b7\u30b9\u3092\u8a98\u5c0e\u3059\u308b. \u7b2c48\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a. 2006\u5e749\u670821\uff5e23\u65e5. \u6a2a\u6d5c. J. Oral.Biosci. 48S: 146.<\/li>\n\n\n\n<li>\u4f0a\u5f93\u3000\u5149\u6d0b\u3001\u5b89\u7530\u3000\u5143\u662d\u3001\u7247\u5ca1\u3000\u55e3\u96c4\u3001\u67f4\u7530\u3000\u5065\u4e00\u90ce. \u9178\u5316\u7684\u30b9\u30c8\u30ec\u30b9\u306e\u30d5\u30a1\u30b4\u30b5\u30a4\u30c8\u30fc\u30b7\u30b9\u306b\u53ca\u307c\u3059\u5f71\u97ff.\u3000\u7b2c48\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a. 2006\u5e749\u670821\uff5e23\u65e5. \u6a2a\u6d5c. J. Oral.Biosci. 48S: 147.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>\u539f\u8457\u8ad6\u6587 \u7dcf\u8aac\u30fb\u89e3\u8aac\u30fb\u8a55\u8ad6 \u56fd\u969b\u5b66\u4f1a\u767a\u8868 \u56fd\u5916\u5b66\u4f1a\u767a\u8868 \u5b66\u4f1a\u767a\u8868<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"vkexunit_cta_each_option":"","footnotes":""},"class_list":["post-263","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.den.hokudai.ac.jp\/microbiology\/wp-json\/wp\/v2\/pages\/263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.den.hokudai.ac.jp\/microbiology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.den.hokudai.ac.jp\/microbiology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/microbiology\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/microbiology\/wp-json\/wp\/v2\/comments?post=263"}],"version-history":[{"count":4,"href":"https:\/\/www.den.hokudai.ac.jp\/microbiology\/wp-json\/wp\/v2\/pages\/263\/revisions"}],"predecessor-version":[{"id":422,"href":"https:\/\/www.den.hokudai.ac.jp\/microbiology\/wp-json\/wp\/v2\/pages\/263\/revisions\/422"}],"wp:attachment":[{"href":"https:\/\/www.den.hokudai.ac.jp\/microbiology\/wp-json\/wp\/v2\/media?parent=263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}